hepatomegaly

(redirected from hepatotoxicity)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

hepatomegaly

[‚hep·əd·ō′meg·ə·lē]
(medicine)
Enlargement of the liver.
References in periodicals archive ?
Among the adverse effects of triptolide, hepatotoxicity is non-negligible with a high incidence.
Hepatotoxicity due to ART may be a result of immune restoration and the development of acute liver injury related to an enhanced immune response to TB or hepatitis B virus (HBV) immune reconstitution inflammatory syndrome (IRIS).
3) If pregnant patients with hepatotoxicity can be treated, avoiding prolonged exposure of the fetus to even a modest amount of unconjugated bilirubin in utero, the effects of hyperbilirubinaemia on the fetus can be minimised.
The risk of nevirapine-induced hepatotoxicity is elevated 12 times in female patients with CD4 counts greater than 250.
Hepatotoxicity was defined as an increase in the AST or ALT level to 5 times the upper limit of normal, an increase in the serum bilirubin level of more than 1.
Protective role of tetrahydrocurcumin, an active principle of turmeric on chloroquine-induced hepatotoxicity in rats.
Importantly, the authors also noted that alcohol use among patients with HIV is not only associated with decreased adherence to their antiretroviral therapy (ART) regimen and reduced HIV suppression, but it also increased the risk of ART-induced hepatotoxicity and high-risk sexual behavior.
Isoniazid and rifampicin given together produce hepatotoxicity more frequently than either drug alone (12-15).
Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure.
Most patients who develop statin hepatotoxicity have been in the sixth or seventh decade, presumably reflecting the demographics of patients who are prescribed these drugs.
This work collects bioassay protocols for evaluating the therapeutic moieties resulting from chemical, biological, and natural processes; for exploring the mechanisms of action of therapeutic moieties in cells, tissues, and organs; and for measuring chemical toxicity and hepatotoxicity of therapeutic compounds.